Finally, a glimmer of hope for those seeking weight loss pills. Orexigen’s Contrave has been recommended for approval by a panel of the FDA (Food and Drug Administration). The panel voted 13-7 in favour of the weight loss drug. We await the decision of the FDA which is due to be announced on the 31st January. The agency usually follows the advice of their panels.
Contrave functions to prevent food cravings. Both of the drugs that combine to form Contrave have a history of safety and efficacy and the results look promising.There is more information on this drug’s efficacy and safety on our own Contrave page.
The cardiovascular outcomes study has yet to be evaluated but it is suggested that this is done after the drug has been approved. The panel voted 11-8 that safety studies should be carried out only after this point.